SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Form
Filing Date
Mar 22, 2021
Document Date
Mar 22, 2021
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc